Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

LATEST INFECTIOUS DISEASE ARTICLES

RSS Latest Infectious Disease Articles
  • Treatment of Hepatitis D — A Future Role for Combination Therapy July 11, 2024
    Hepatitis D virus (HDV) infection is the most serious form of viral hepatitis, with an accelerated clinical course and heightened risks of cirrhosis and liver cancer.1 No therapies for HDV infection have been approved by the Food and Drug Administration (FDA), which has made the management of this...
    Norah Terrault
  • Lipschütz’s Ulcer July 11, 2024
    A previously healthy 17-year-old girl presented with a 7-day history of painful genital ulcers. Eight days before the onset of the ulcers, she had had fever, malaise, and a sore throat.
    Daniela Costa, Patricia Carvalho
  • Funding Postauthorization Vaccine-Safety Science July 11, 2024
    The slow speed of science contributes to public concern about vaccines and reduced immunization coverage. Postauthorization safety research requires timely funding linked to the introduction of new vaccines.
    Daniel A. Salmon, Walter A. Orenstein, Stanley A. Plotkin, Robert T. Chen

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.